Voltaren 25 Tablets

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

diclofenac sodium, Quantity: 25 mg

Disponible depuis:

Novartis Pharmaceuticals Australia Pty Ltd

forme pharmaceutique:

Tablet, enteric coated

Composition:

Excipient Ingredients: purified talc; povidone; iron oxide yellow; maize starch; PEG-40 hydrogenated castor oil; lactose monohydrate; magnesium stearate; colloidal anhydrous silica; hypromellose; microcrystalline cellulose; acrylates copolymer; macrogol 8000; titanium dioxide; sodium starch glycollate; steareth-2; simethicone; sorbic acid

Mode d'administration:

Oral

Unités en paquet:

20, 50

classe:

Medicine Registered

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

INDICATIONS AS AT 19 MAY 2004: Inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. Relief of acute or chronic pain states in which there is an inflammatory component. Symptomatic treatment of primary dysmenorrhoea.

Descriptif du produit:

Visual Identification: yellow, round, slightly biconvex tablets with bevelled edges. Imprinted with BZ on one side and CG on the other; Container Type: Bottle; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius

Statut de autorisation:

Registered

Date de l'autorisation:

1991-08-02